secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keenova Therapeutics plc (—)
CIK:        0001567892
Form:       8-K
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001104659-25-099660
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mallinckrodt issues 45,564 preferred shares per ordinary share to enable potential Par Health spin-off
--------------------------------------------------------------------------------

- Issued 45,564 preferred shares for each ordinary share held as of Oct 8, 2025, effective Oct 10, 2025.
- Preferred shares have no voting or dividend rights; redeemable at board's discretion for nil consideration.
- Transfer restricted: must be in blocks of 45,564 with a stapled ordinary share transfer.
- Authorized share capital increased to $3.005B and €25k, creating 3 trillion preferred shares.
- Board has not yet authorized the potential spin-off of Par Health; this issuance is preparatory.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567892/000110465925099660/0001104659-25-099660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567892/000110465925099660/tm2528698d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-099660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer